0 likes | 1 Views
The Continuous Glucose Monitoring Device market is projected to grow from US$ 12.63 billion in 2024 to US$ 32.97 billion by 2031; the market is estimated to record a CAGR of 12.6% during 2025u20132031.<br><br>
E N D
Continuous Glucose Monitoring Device (CGMD) Market Forecast (2024–2031) Market Insights, Growth Drivers, Trends & Strategic Outlook Source: The Insight Partners
Market Overview $12.63B $32.97B 12.6% 2024 Market Size 2031 Projection CAGR Growth Current valuation of the global CGMD market Expected market value by the end of forecast period Compound annual growth rate from 2025-2031 The robust forecast is driven primarily by increasing adoption of continuous monitoring devices over traditional self-monitoring methods, despite occasional product recalls presenting market restraints.
Key Market Drivers Rising Diabetes Prevalence Global diabetes rates continue to climb, expanding the potential user base for CGMDs. Real-Time Monitoring Shift Prevention of hypoglycemia and hyperglycemia through continuous data availability. Smart Technology Integration Advanced sensors, transmitters and monitors creating comprehensive management systems. Pandemic Innovation Boost COVID-19 accelerated medical device development and remote monitoring adoption.
Segmental Analysis Transmitters Essential components for data relay in CGMD systems Sensors Largest market share and fastest growing segment with 14.6% CAGR Receivers Devices that collect and display glucose monitoring data By Application By Testing Site By End User • Type 1 Diabetes • Fingertip • Hospitals & Clinics • Type 2 Diabetes • Alternate Site • Self/Homecare
Technology & Innovation Trends Automated Insulin Delivery Integration Mobile Application Synchronization Emerging Product Developments Seamless connectivity between monitoring and delivery systems creating closed-loop solutions App-based monitoring enabling patients to track glucose levels directly from their phones Dexcom's FDA filing for Stelo Glucose Sensor (2024) representing next-generation technology Key Business Insight: Sensors account for 60-90% of major CGMD company revenues, with growing focus on expanding into low and middle-income country markets.
Regional Insights North America Europe Asia-Pacific Market leader with highest adoption rates and presence of major manufacturers Strong healthcare infrastructure supporting steady CGMD market growth Fastest growing region due to rising diabetes prevalence and improving healthcare access South/Central America Middle East & Africa Emerging market with increasing diabetes awareness and healthcare spending Growing potential with improving healthcare infrastructure and rising chronic disease burden
Thank You Website www.theinsightpartners.com Phone +91-20-69018686 Email sales@theinsightpartners.com